SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-047872
Filing Date
2023-04-20
Accepted
2023-04-20 17:15:46
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-20

Document Format Files

Seq Description Document Type Size
1 ARS tm2313122d2_ars.pdf ARS 231160
  Complete submission text file 0001104659-23-047872.txt   319909
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-12957 | Film No.: 23833928
SIC: 2836 Biological Products, (No Diagnostic Substances)